Background: Breast-conserving surgery has been established as the standard surgical treatment for most patients with early breast cancer, providing overall survival and recurrence rate equivalent. The aim of this work was to evaluate the outcomes of lipofilling (fat grafting) after breast conserving surgery for patients with unilateral breast cancer.
Methods: This prospective study was carried out on 25 patients aged ≥ 18 years old, females only, with breast cancer that is candidate for breast conserving surgery. All patients were subjected to history taking, clinical examination [General examination, and local breast examination], radiological assessment [breast ultrasound, mammography, magnetic resonance imaging, and metastatic workup], biopsy (core biopsy), and laboratory investigations.
Results: The duration of hospitalization was two days in all cases. Early complications included wound infection (12%) and hematoma (4%). Late complications included clinically significant seroma (12%) and fat necrosis (8%). Neither of these patients required readmission. Additionally, no patients developed or show any signs of recurrence during the scheduled six-month follow-up visits. About surgeons' satisfaction, most surgeons reported very good results regarding the five aspects of the used score. The same was also reported when the same questionnaire was answered by the patients. Patient satisfaction showed satisfactory results about the surgery.
Conclusions: Lipofilling after breast conserving surgery for breast cancer is a safe and efficacious procedure. The safety is manifested in the acceptable morbidity rate, while the efficacy is manifested by the excellent cosmetic outcomes after the procedure.